Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Robbins

Showing results (121-130 of 258) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomeraseMaria R Parkhurst, John P Riley, Takehito Igarashi, et al.
Cancer Research|August 29, 1998
Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigensR F Wang, X Wang, S L Johnston, et al.
Science Immunology|January 13, 2019
Tumor-infiltrating human CD4<sup>+</sup> regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivityMojgan Ahmadzadeh, Anna Pasetto, Li Jia, et al.
Clinical Chemistry|January 1, 1974
CEA-like material in fluid from benign cysts of the breastM Fleisher, H F Oettgen, C N Breed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytesP F Robbins, M El-Gamil, Y F Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene productJianping Huang, Mona El-Gamil, Mark E Dudley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor typesM Harada, Y F Li, M El-Gamil, et al.
Journal of the National Cancer Institute|March 1, 1975
In vitro studies of axillary lymph node cells in patients with breast cancerE Tsakraklides, V Tsakraklides, H Ashikari, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase geneS L Topalian, L Rivoltini, M Mancini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cellsMaria R Parkhurst, Jayne Joo, John P Riley, et al.
Pageof 26

Showing results (121-130 of 258) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomeraseMaria R Parkhurst, John P Riley, Takehito Igarashi, et al.
Cancer Research|August 29, 1998
Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigensR F Wang, X Wang, S L Johnston, et al.
Science Immunology|January 13, 2019
Tumor-infiltrating human CD4<sup>+</sup> regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivityMojgan Ahmadzadeh, Anna Pasetto, Li Jia, et al.
Clinical Chemistry|January 1, 1974
CEA-like material in fluid from benign cysts of the breastM Fleisher, H F Oettgen, C N Breed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytesP F Robbins, M El-Gamil, Y F Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene productJianping Huang, Mona El-Gamil, Mark E Dudley, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor typesM Harada, Y F Li, M El-Gamil, et al.
Journal of the National Cancer Institute|March 1, 1975
In vitro studies of axillary lymph node cells in patients with breast cancerE Tsakraklides, V Tsakraklides, H Ashikari, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase geneS L Topalian, L Rivoltini, M Mancini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cellsMaria R Parkhurst, Jayne Joo, John P Riley, et al.
Pageof 26